Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

900 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early steps of follicular lymphoma pathogenesis.
Roulland S, Faroudi M, Mamessier E, Sungalee S, Salles G, Nadel B. Roulland S, et al. Among authors: salles g. Adv Immunol. 2011;111:1-46. doi: 10.1016/B978-0-12-385991-4.00001-5. Adv Immunol. 2011. PMID: 21970951 Review.
Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study.
Michot JM, Canioni D, Driss H, Alric L, Cacoub P, Suarez F, Sibon D, Thieblemont C, Dupuis J, Terrier B, Feray C, Tilly H, Pol S, Leblond V, Settegrana C, Rabiega P, Barthe Y, Hendel-Chavez H, Nguyen-Khac F, Merle-Béral H, Berger F, Molina T, Charlotte F, Carrat F, Davi F, Hermine O, Besson C; ANRS HC-13 Lympho-C Study Group. Michot JM, et al. Am J Hematol. 2015 Mar;90(3):197-203. doi: 10.1002/ajh.23889. Epub 2014 Nov 24. Am J Hematol. 2015. PMID: 25417909 Free article. Clinical Trial.
[No title available]
[No authors listed] [No authors listed] PMID: 39112235
Predictors and implications of renal injury after CD19 chimeric antigen receptor T-cell therapy.
Boardman AP, Gutgarts V, Flynn J, Devlin SM, Goldman A, Tomas AA, Fein JA, Slingerland JB, Parascondola A, Lin RJ, Scordo M, Dahi PB, Giralt S, Palomba ML, Salles G, Nath K, Walji M, Corona M, Park JH, Shah GL, Perales MA, Jaffer-Sathick I, Shouval R. Boardman AP, et al. Among authors: salles g. Haematologica. 2024 Nov 21. doi: 10.3324/haematol.2024.286021. Online ahead of print. Haematologica. 2024. PMID: 39568416 Free article.
Cancer cachexia and weight loss prior to CAR T-cell therapy for lymphoma are independently associated with poor outcomes.
Valtis YK, Devlin SM, Shouval R, Rejeski K, Corona M, Luna De Abia A, Rivas-Delgado A, Luttwak E, Cassanello G, Landego I Dr, Schöder H, Bedmutha A, Boardman AP, Shah GL, Scordo M, Perales MA, Salles GA, Palomba ML, Shah UA, Park JH. Valtis YK, et al. Among authors: salles ga. Blood Adv. 2024 Oct 29:bloodadvances.2024014555. doi: 10.1182/bloodadvances.2024014555. Online ahead of print. Blood Adv. 2024. PMID: 39471490
Shift from Widespread to Tailored Antifungal Prophylaxis in Lymphoma Patients Treated with CD19 CAR T Cell Therapy: Results from a Large Retrospective Cohort.
Melica G, Luna de Abia A, Shah GL, Devlin S, Corona M, Fein J, Dahi PB, Giralt SA, Lin RJ, Palomba ML, Parascondola A, Park J, Salles G, Saldia A, Scordo M, Shouval R, Perales MA, Seo SK. Melica G, et al. Among authors: salles g. Transplant Cell Ther. 2024 Oct 22:S2666-6367(24)00727-9. doi: 10.1016/j.jtct.2024.10.010. Online ahead of print. Transplant Cell Ther. 2024. PMID: 39448032 Free article.
Zanubrutinib, Obinutuzumab, and Venetoclax for First-Line Treatment of Mantle Cell Lymphoma with a TP53 Mutation.
Kumar A, Soumerai JD, Abramson JS, Barnes JA, Caron PC, Chhabra S, Chabowska M, Dogan A, Falchi L, Grieve C, Haydu JE, Johnson PC, Joseph A, Kelly H, Labarre A, Lue JK, Martignetti R, Mi J, Moskowitz AJ, Owens CN, Plummer S, Puccio M, Salles GA, Seshan VE, Simkins E, Slupe N, Zhang H, Zelenetz AD. Kumar A, et al. Among authors: salles ga. Blood. 2024 Oct 22:blood.2024025563. doi: 10.1182/blood.2024025563. Online ahead of print. Blood. 2024. PMID: 39437708
900 results